vs

Side-by-side financial comparison of ABERCROMBIE & FITCH CO (ANF) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.

ABERCROMBIE & FITCH CO is the larger business by last-quarter revenue ($1.3B vs $1.1B, roughly 1.2× PERRIGO Co plc). ABERCROMBIE & FITCH CO runs the higher net margin — 8.8% vs -127.8%, a 136.6% gap on every dollar of revenue. On growth, ABERCROMBIE & FITCH CO posted the faster year-over-year revenue change (6.8% vs -2.5%). PERRIGO Co plc produced more free cash flow last quarter ($148.6M vs $131.8M). Over the past eight quarters, PERRIGO Co plc's revenue compounded faster (1.3% CAGR vs -5.8%).

Abercrombie & Fitch Co. (A&F) is an American lifestyle retailer founded in 1892, which focuses on contemporary clothing targeting customers in their early 20s to mid 40s. Headquartered in New Albany, Ohio, the company operates four offshoot brands: Abercrombie Kids, Your Personal Best, Hollister Co., and Gilly Hicks with 780+ company operated stores across its brands, as of Q4 2024.

Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...

ANF vs PRGO — Head-to-Head

Bigger by revenue
ANF
ANF
1.2× larger
ANF
$1.3B
$1.1B
PRGO
Growing faster (revenue YoY)
ANF
ANF
+9.3% gap
ANF
6.8%
-2.5%
PRGO
Higher net margin
ANF
ANF
136.6% more per $
ANF
8.8%
-127.8%
PRGO
More free cash flow
PRGO
PRGO
$16.8M more FCF
PRGO
$148.6M
$131.8M
ANF
Faster 2-yr revenue CAGR
PRGO
PRGO
Annualised
PRGO
1.3%
-5.8%
ANF

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
ANF
ANF
PRGO
PRGO
Revenue
$1.3B
$1.1B
Net Profit
$113.0M
$-1.4B
Gross Margin
62.5%
32.6%
Operating Margin
12.0%
-116.0%
Net Margin
8.8%
-127.8%
Revenue YoY
6.8%
-2.5%
Net Profit YoY
-14.4%
-3093.9%
EPS (diluted)
$2.36
$-10.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ANF
ANF
PRGO
PRGO
Q4 25
$1.3B
$1.1B
Q3 25
$1.2B
$1.0B
Q2 25
$1.1B
$1.1B
Q1 25
$1.6B
$1.0B
Q4 24
$1.2B
$1.1B
Q3 24
$1.1B
$1.1B
Q2 24
$1.0B
$1.1B
Q1 24
$1.5B
$1.1B
Net Profit
ANF
ANF
PRGO
PRGO
Q4 25
$113.0M
$-1.4B
Q3 25
$141.4M
$7.5M
Q2 25
$80.4M
$-8.4M
Q1 25
$187.2M
$-6.4M
Q4 24
$132.0M
$-44.4M
Q3 24
$133.2M
$-21.0M
Q2 24
$113.8M
$-108.4M
Q1 24
$158.4M
$2.0M
Gross Margin
ANF
ANF
PRGO
PRGO
Q4 25
62.5%
32.6%
Q3 25
62.6%
36.1%
Q2 25
62.0%
34.4%
Q1 25
37.6%
Q4 24
65.1%
33.9%
Q3 24
64.9%
37.2%
Q2 24
66.4%
37.0%
Q1 24
62.9%
33.1%
Operating Margin
ANF
ANF
PRGO
PRGO
Q4 25
12.0%
-116.0%
Q3 25
17.1%
7.0%
Q2 25
9.3%
4.3%
Q1 25
16.2%
4.5%
Q4 24
14.8%
10.0%
Q3 24
15.5%
7.4%
Q2 24
12.7%
-2.5%
Q1 24
15.3%
-5.1%
Net Margin
ANF
ANF
PRGO
PRGO
Q4 25
8.8%
-127.8%
Q3 25
11.7%
0.7%
Q2 25
7.3%
-0.8%
Q1 25
11.8%
-0.6%
Q4 24
10.9%
-3.9%
Q3 24
11.7%
-1.9%
Q2 24
11.2%
-10.2%
Q1 24
10.9%
0.2%
EPS (diluted)
ANF
ANF
PRGO
PRGO
Q4 25
$2.36
$-10.23
Q3 25
$2.91
$0.05
Q2 25
$1.59
$-0.06
Q1 25
$3.55
$-0.05
Q4 24
$2.50
$-0.32
Q3 24
$2.50
$-0.15
Q2 24
$2.14
$-0.79
Q1 24
$2.97
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ANF
ANF
PRGO
PRGO
Cash + ST InvestmentsLiquidity on hand
$631.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.3B
$2.9B
Total Assets
$3.5B
$8.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ANF
ANF
PRGO
PRGO
Q4 25
$631.0M
Q3 25
$603.5M
$432.1M
Q2 25
$607.6M
$454.2M
Q1 25
$888.9M
$409.9M
Q4 24
$738.9M
$558.8M
Q3 24
$738.4M
$1.5B
Q2 24
$864.2M
$542.8M
Q1 24
$900.9M
$658.5M
Stockholders' Equity
ANF
ANF
PRGO
PRGO
Q4 25
$1.3B
$2.9B
Q3 25
$1.3B
$4.4B
Q2 25
$1.2B
$4.5B
Q1 25
$1.3B
$4.4B
Q4 24
$1.2B
$4.3B
Q3 24
$1.2B
$4.6B
Q2 24
$1.1B
$4.5B
Q1 24
$1.0B
$4.7B
Total Assets
ANF
ANF
PRGO
PRGO
Q4 25
$3.5B
$8.5B
Q3 25
$3.3B
$10.1B
Q2 25
$3.1B
$10.1B
Q1 25
$3.3B
$9.8B
Q4 24
$3.3B
$9.6B
Q3 24
$3.0B
$11.2B
Q2 24
$3.0B
$10.4B
Q1 24
$3.0B
$10.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ANF
ANF
PRGO
PRGO
Operating Cash FlowLast quarter
$200.1M
$175.4M
Free Cash FlowOCF − Capex
$131.8M
$148.6M
FCF MarginFCF / Revenue
10.2%
13.4%
Capex IntensityCapex / Revenue
5.3%
2.4%
Cash ConversionOCF / Net Profit
1.77×
TTM Free Cash FlowTrailing 4 quarters
$384.5M
$145.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ANF
ANF
PRGO
PRGO
Q4 25
$200.1M
$175.4M
Q3 25
$116.9M
$51.7M
Q2 25
$-4.0M
$75.9M
Q1 25
$307.6M
$-64.5M
Q4 24
$142.6M
$312.6M
Q3 24
$165.1M
$42.2M
Q2 24
$95.0M
$9.5M
Q1 24
$303.3M
$-1.4M
Free Cash Flow
ANF
ANF
PRGO
PRGO
Q4 25
$131.8M
$148.6M
Q3 25
$50.7M
$29.8M
Q2 25
$-54.8M
$56.7M
Q1 25
$256.8M
$-90.0M
Q4 24
$92.2M
$274.9M
Q3 24
$122.3M
$15.1M
Q2 24
$56.1M
$-18.9M
Q1 24
$274.1M
$-26.5M
FCF Margin
ANF
ANF
PRGO
PRGO
Q4 25
10.2%
13.4%
Q3 25
4.2%
2.9%
Q2 25
-5.0%
5.4%
Q1 25
16.2%
-8.6%
Q4 24
7.6%
24.2%
Q3 24
10.8%
1.4%
Q2 24
5.5%
-1.8%
Q1 24
18.9%
-2.4%
Capex Intensity
ANF
ANF
PRGO
PRGO
Q4 25
5.3%
2.4%
Q3 25
5.5%
2.1%
Q2 25
4.6%
1.8%
Q1 25
3.2%
2.4%
Q4 24
4.2%
3.3%
Q3 24
3.8%
2.5%
Q2 24
3.8%
2.7%
Q1 24
2.0%
2.3%
Cash Conversion
ANF
ANF
PRGO
PRGO
Q4 25
1.77×
Q3 25
0.83×
6.89×
Q2 25
-0.05×
Q1 25
1.64×
Q4 24
1.08×
Q3 24
1.24×
Q2 24
0.83×
Q1 24
1.91×
-0.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ANF
ANF

Hollister$673.3M52%
Abercrombie$617.3M48%
Gift Card$25.7M2%
Royalty$19.5M2%

PRGO
PRGO

Consumer Self Care Americas$697.0M63%
Digestive Health$123.9M11%
Nutrition$108.3M10%
Healthy Lifestyle$94.8M9%
Pain And Sleep Aids$87.1M8%

Related Comparisons